Lee Krug, MD, discusses the current state of mesothelioma treatments as well as new therapies in development. He mentions the possibilities of clinical trials for angiogenesis inhibitors and anti-VEGF antibodies for mesothelioma within the next 1 to 2 years. This interview was filmed at the “Malignant Mesothelioma: Knowledge Is Hope“ Conference on September 28, 2012. Read more about Lee Krug. View presentation slides for the conference.